Cargando…

Remdesivir for treatment of COVID-19; an updated systematic review and meta-analysis

The coronavirus disease 2019 (COVID-19) pandemic has become a global health crisis. Considering the recent food and drug administration (FDA) approval of remdesivir as the first officially approved agent for COVID-19 treatment, we performed this systematic review and meta-analysis to evaluate the ef...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rezagholizadeh, Afra, Khiali, Sajad, Sarbakhsh, Parvin, Entezari-Maleki, Taher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859696/ https://www.ncbi.nlm.nih.gov/pubmed/33549577 http://dx.doi.org/10.1016/j.ejphar.2021.173926

Ejemplares similares

SARS-CoV-2 and probable lung cancer risk
por: Khiali, Sajad, et al.
Publicado: (2022)

Empagliflozin and colchicine in patients with reduced left ventricular ejection fraction following ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: a study protocol for a randomized, double-blinded, three-arm parallel-group, controlled trial
por: Khiali, Sajad, et al.
Publicado: (2023)

Tocilizumab in COVID-19 management: addressing time of starting treatment
por: Khiali, Sajad, et al.
Publicado: (2023)

Anticoagulation in COVID-19: DDI Perspective
por: Khiali, Sajad, et al.
Publicado: (2020)

Potential pharmacologic treatments for COVID-19 smell and taste loss: A comprehensive review
por: Khani, Elnaz, et al.
Publicado: (2021)

Comprehensive review on molnupiravir in COVID-19: a novel promising antiviral to combat the pandemic
por: Khiali, Sajad, et al.
Publicado: (2022)

Isotretinoin; A review on the Utilization Pattern in Pregnancy
por: Khiali, Sajad, et al.
Publicado: (2018)

Remdesivir for the treatment of COVID-19: a systematic review and meta-analysis
por: Lee, Todd C., et al.
Publicado: (2022)

An Updated Systematic Review on Remdesivir’s Safety and Efficacy in Patients Afflicted With COVID-19
por: Yasir, Mohamed, et al.
Publicado: (2023)

Addendum to Systematic Review of Remdesivir for the Treatment of COVID-19
por: Musa, Arif, et al.
Publicado: (2020)

Fluvoxamine and long COVID-19; a new role for sigma-1 receptor (S1R) agonists
por: Khani, Elnaz, et al.
Publicado: (2022)

Efficacy and harms of remdesivir for the treatment of COVID-19: A systematic review and meta-analysis
por: Piscoya, Alejandro, et al.
Publicado: (2020)

SYSTEMATIC REVIEW AND META-ANALYSIS OF REMDESIVIR AND BRADYCARDIA IN PATIENTS WITH COVID-19
por: Jipescu, Daniel, et al.
Publicado: (2022)

Remdesivir for the Treatment of COVID-19: A Systematic Review of the Literature
por: Musa, Arif, et al.
Publicado: (2020)

Remdesivir for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials
por: Al-Abdouh, Ahmad, et al.
Publicado: (2021)

ICER update to pricing models of remdesivir for COVID-19
Publicado: (2020)

A commentary on “Unexpected sudden rise of human monkeypox cases in multiple non-endemic countries amid COVID-19 pandemic and salient counteracting strategies: Another potential global threat?” (Int J Surg 2022;103:106705)
por: Khani, Elnaz, et al.
Publicado: (2022)

Mortality Benefit of Remdesivir in COVID-19: A Systematic Review and Meta-Analysis
por: Bansal, Vikas, et al.
Publicado: (2021)

Use of remdesivir in patients with COVID-19: a systematic review and meta-analysis
por: Tanni, Suzana E, et al.
Publicado: (2022)

ICER's second update to pricing models of remdesivir for COVID-19
Publicado: (2020)

Positive association between severity of COVID-19 infection and liver damage: a systematic review and meta-analysis
por: Shokri Afra, Hajar, et al.
Publicado: (2020)

Efficacy and safety of remdesivir in hospitalised COVID-19 patients: a systematic review and meta-analysis
por: Angamo, Mulugeta T., et al.
Publicado: (2021)

Protocol: Benefits and harms of remdesivir for COVID-19 in adults: A systematic review with meta-analysis
por: Paludan-Müller, Asger Sand, et al.
Publicado: (2021)

The place for remdesivir in COVID-19 treatment
por: Young, Barnaby, et al.
Publicado: (2021)

Drug‐drug interactions with candidate medications used for COVID‐19 treatment: An overview
por: Rezaee, Haleh, et al.
Publicado: (2021)

Remdesivir: A Review in COVID-19
por: Blair, Hannah A.
Publicado: (2023)

Effectiveness of Remdesivir, Lopinavir/Ritonavir, and Favipiravir for COVID-19 Treatment: A Systematic Review
por: Qomara, Windi Fresha, et al.
Publicado: (2021)

Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review
por: Rezapour, Aziz, et al.
Publicado: (2023)

The efficacy and safety of remdesivir alone and in combination with other drugs for the treatment of COVID-19: a systematic review and meta-analysis
por: Chen, Chuizhe, et al.
Publicado: (2023)

Remdesivir in Treatment of COVID-19: A Systematic Benefit–Risk Assessment
por: Davies, Miranda, et al.
Publicado: (2020)

Commentary on ‘Implications of the SARS-CoV-2 subvariants BA.4 and BA.5’
por: Khani, Elnaz, et al.
Publicado: (2023)

Enoxaparin’s potential mechanisms against SARS-CoV-2
por: Afsharirad, Bentelhoda, et al.
Publicado: (2023)

Remdesivir and COVID-19
por: Ferrara, Francesco, et al.
Publicado: (2020)

Remdesivir for COVID-19
Publicado: (2020)

Remdesivir and COVID-19
por: Glaus, Matthew J, et al.
Publicado: (2020)

Remdesivir and COVID-19
por: Wang, Lei-Yun, et al.
Publicado: (2020)

Remdesivir and COVID-19
por: Dennis, Alicia
Publicado: (2020)

Remdesivir and COVID-19
por: Edwards, Jessie K, et al.
Publicado: (2020)

Remdesivir therapy in patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials
por: Reddy Vegivinti, Charan Thej, et al.
Publicado: (2021)

Remdesivir for pregnancy: A systematic review of antiviral therapy for COVID-19
por: Budi, David Setyo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q18dns1i7ed6qlnhfg54k0ltb2